4.5 Article

The Science Behind Biosimilars Entering a New Era of Biologic Therapy

Journal

ARTHRITIS & RHEUMATOLOGY
Volume 70, Issue 3, Pages 334-344

Publisher

WILEY
DOI: 10.1002/art.40388

Keywords

-

Categories

Funding

  1. Eli Lilly and Company
  2. Sanofi
  3. Janssen
  4. AbbVie
  5. Pfizer
  6. Medac
  7. Coherus
  8. Boehringer Ingelheim
  9. Bristol-Myers Squibb
  10. Janssen Biotech
  11. Merck Sharp Dohme
  12. Roche Laboratories
  13. Samsung Bioepis
  14. UCB
  15. Amgen
  16. Sandoz
  17. Merck

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available